, presumably rederived cells; concomitantly, resident synovial macrophages and fibroblasts become activated and divide.
quired for positive selection of the R28 specificity. The resulting offspring expressed both transgene-encoded The different leukocyte and synoviocyte constituents produce a complex melange of cytokines and other sol-TCR chains on a large proportion of T lymphocytes in the thymus and periphery, and a vigorous proliferative uble mediators, which are thought to be responsible, directly or indirectly, for the characteristic neovasculariresponse could be elicited when their lymph node cells were challenged with the bovine RNase 41-61 peptide in zation, cartilage destruction, and bone erosion. Systemic manifestations may ensue, including elevated the presence of A k -expressing antigen presenting cells (APCs) (Kouskoff, 1994 ; data not shown). Curiously, titers of autoantibodies in the blood, vasculitis, or abnormalities of other organs, e.g. the lung.
though, the TCR transgenes did not promote skewing of T cells into the mature CD4 ϩ compartment of either RA is an important disease, affecting a significant portion ‫)%1ف(‬ of the population and inflicting substantial the thymus or periphery of animals expressing A k , as was expected from previous results in analogous TCR pain and disability. It is also a mysterious disease. We transgenic systems (Berg et al., 1989) . In fact, by most measures of positive selection, the T cell compartments ‡ Present address: National Jewish Center for Immunology and Reof animals on the "selecting" H-2 k and "nonselecting"
spiratory Medicine, 1400 Jackson Street, Denver, Colorado 80206. § These authors contributed equally.
H-2 b backgrounds were quite similar, suggesting poor selection of transgene-encoded TCRs in both cases, but some peripheral emergence of the R28 specificity, nonetheless, probably due to "piggy-backing" with receptors encoded by endogenous TCR genes that had bypassed allelic exclusion (Borgulya et al., 1992) . At that point, KRN did not appear to be a very useful line: transgene-encoded TCRs were expressed quite efficiently, but were ineffective at promoting allele-specific positive selection. Fortunately, and quite fortuitously, we also crossed KRN to the NOD strain.
Development of Arthritis in KRNxNOD Mice
When the KRN line was crossed with the NOD strain, a surprising phenotype appeared in the offspring: transgene-positive, but not transgene-negative, mice exhibited pronounced joint inflammation (compare Figure 1A right and left). In the transgene-positives, all of the distal joints of the paws were swollen and red. As the animals aged, a variety of deformations became evident-e.g., hyperextension of the ankle, valgus deviation of the function and the quality of the skin and nails). Since this Each solid line represents a single mouse. The dashed line shows disease was ostensibly similar to rheumatoid arthritis, the maximum value for control mice at these ages.
we undertook an extensive characterization, assessing 
Clinical Onset
hip joint was unaffected, even in animals whose knees were completely destroyed. Inflammation of the spine To quantitate disease onset, we measured ankle thickwas noted in some regions of some animals; however, ness in a cohort of transgene-positive and -negative it differed markedly from the typical limb joint inflammalittermates beginning shortly after birth. Figure 1C demtion in its mild and variable appearance. onstrates a sharp onset of swelling at 25-35 days in the Fluorescent antibody staining of cryostat sections of former but not the latter. This panel also illustrates the the knee joint revealed that the most abundant cell types complete penetrance of the disease; indeed, in the hunwere of the macrophage lineage, identified by their staindreds of animals by now examined, we have observed ing with the MAC-1 and MOMA-1 markers (Figures 2I joint inflammation in all of the KRNxNOD TCR transand 2J). T lymphocytes were less frequent, even at the genics and none of the transgene-negative littermates earliest stages of disease, and were usually found in (also see below). This was true whether the mice were small clusters ( Figure 2K) ; B cells were even rarer (not housed under specific-pathogen-free or conventional shown). Cytofluorimetric analysis of ankle synovial fluid conditions.
showed a somewhat different composition in the articuComparison of the curves for any two individuals in lar cavity ( Figure 2L ). There was a minor population of Figure 1C revealed a degree of heterogeneity in disease small CD3 ϩ T lymphocytes (1%-3%) and a vast majority initiation and course. However, when curves for the two of large Mac-1-positive cells. Most of these were neutrolimbs of individual animals were compared ( Figure 1D ), phils, identified by their scatter profiles and strong stainthey were always precisely superimposable. Symmetry ing with an anti-GR-1 mAb, but their was also a small of involvement also appeared true of the other inflamed component of GR-1 ϩ/Ϫ , surface immunoglobulin (sIg) ϩ joints, according to simple by-eye inspection. cells. The paucity of lymphocytes in the joint was reJoint Histology flected in the profile of cytokines detected-by PCR To visualize the pathological processes underlying analyses of cells in the synovial fluid: undetectable inthese clinical manifestations, we performed histological terleukin (IL)-4, barely measurable IL-2 and interferon analysis of knee joints (Figure 2 ). In the joint from a (IFN)-␥, and high levels of tumor necrosis factor (TNF)-␣; normal mouse (Figure 2A ), the articular cavity was acelby ELISA assays of protein in the synovial liquid: undelular, the synovial lining a thin unicellular layer covering tectable IL-4, IL-10, IFN-␥, TNF-␣, and granulocyte/macadipose and connective tissue, and the cartilage smooth rophage-colony stimulating factor (GM-CSF), and enorand uniform. At disease onset in KRNxNOD mice ( Figure  mous quantities of IL-6 (0.5-20 g/ml) (not shown). 2B), the lesions were quite discrete: fibrinoid material Skeletal preparations were made from animals three and a few cells were found in the cavity; edema set in to six months after disease onset to better document under the synovial lining, accompanied by neovascularithe distribution and extent of bone destruction (Figure zation and some infiltration of inflammatory cells (seen 3). Damage was massive in the paws ( Figure 3A ), affectbetter at higher power in Figure 2E ); and bone and cartiing all interphalangial, metatarsal, and tarsal joints (and lage were largely unaffected. After a few weeks of evolutheir forelimb equivalents); the calcaneum was also tion ( Figure 2C ), disease was marked by extensive synodamaged. A close-up view of the interphalangial joints vitis, affecting all areas of the joint. The synovium was ( Figure 3B ) depicts a typical image of bone erosion tohyperplastic, with massive infiltration of inflammatory gether with anarchic reconstruction; very similar piccells and the beginnings of fibrosis ( Figure 2F ). In some tures were found with the knee joint ( Figure 3C ). In conareas, small nodules developed, seemingly composed trast, the sacro-iliac joint always appeared intact (Figure of lymphocytes. Abundant fibrinoid material and inflam-3D), as did the hip ( Figure 3E ). Consistent with the histomatory cells, mainly neutrophils in appearance, exuded logical findings described above, most of the vertebral from the inflamed synovium into the articular cavity. The joints were unaffected, but signs of destruction were synovitis extended over some areas of cartilage, forming detected sporadically (arrow in Figure 3F ). a typical pannus, which invaded the cartilage and underImmunological Analysis lying bone; chondrocytes in their niches were pyknotic Lastly, we examined immunological parameters af-( Figure 2G ). After several months of disease, the knee fected in certain of the human arthritides. Splenomegaly joint presented an anarchic picture ( Figure 2D ). The inwas often noted, and B lymphocyte numbers were inflammatory process had largely receded, but the archicreased in the lymph nodes and spleen of diseased tecture of the joint was completely remodeled: little caranimals (on average 1.75-fold; n ϭ 7). However, B cells tilage remained and the residual bone adopted irregular did not appear to be in an abnormal activation state as structures, embedded in the massive fibrosis that now assessed by size, IgM/IgD profile, or staining intensity made up most of the joint ( Figure 2H ).
with anti-CD69, -CD5, or -MHC class II reagents (not Similar lesions were detected in the distal joints of shown). In addition, the follicular organization (follicle, the limbs of all KRNxNOD mice examined-including mantle zone, germinal centers) appeared entirely northe metatarsal, tarsal, ankle and knee joints, and the mal. Hypergammaglobulinemia was also evident, essentially due to an increase in the IgG1 isotype ( Figure 4A ). corresponding forelimb articulations. Interestingly, the Nonetheless, circulating antoantibodies could not be from crosses between B6 and other inbred strains (BALB/c, DBA/2) showed no overt pathology. detected-including anti-dsDNA or rheumatoid factor (RF; IgM anti-IgG) ( Figure 4B ) and antibodies capable
The NOD strain is prone to autoimmune diseasemost notably diabetes, but also sialitis, thyroiditis, and of binding to sections of liver or kidney (not shown).
others (Tisch and McDevitt, 1996) . Both its peculiar MHC However, vast IgG deposits were observed on sections allele, H-2 g7 , and multiple non-MHC genes play a role in of many organs, mainly along the basal membranes, in promoting autoimmunity (Wicker et al., 1995) . To distina pattern that is distinctly different from that observed guish the contribution of MHC from non-MHC NODin diseases due to immune complex deposition, e.g. in derived genes in our arthritis model, we crossed KRN MRL/lpr or NZBxNZW mice ( Figures 4C-4G ). IgG deposwith a B6 line congenic for the NOD MHC. The offspring its were first seen some weeks after the initial signs of (B6xB6.H-2 g7 ) had one MHC allele originating from the arthritis and were not associated with any other histolog-B6 and one from the NOD strain; all non-MHC genes ical abnormalities.
were B6-derived. These animals all showed overt signs As will be discussed in detail below, the overall image of arthritis (Table 1 ), indicating that the only required of disease in KRNxNOD mice-synthesized from diverse contribution from the NOD genome was one H-2 g7 allele.
clinical, histological and immunological features-is
The NOD MHC is a complex recombinant haplotype, highly reminiscent of (though not identical to) rheumacarrying d-alleles on the H-2K end, an unusual allele toid arthritis in human patients. Thus, although it was (g7) at the A ␤ locus, and b-alleles on the H-2D end. That generated entirely unintentionally, we saw this as a poneither B6xBALB/c nor straight B6 transgene-positive tentially powerful model and have focused on unravelmice showed signs of pathology suggested that K Figure 5A ) or a hybridoma between NOD splenocytes and the M12 B lymphoma line (not shown); responders could be either the original T hybridoma R28 (not shown) or lymph node T cells from KRN transgenics on the B6 background ( Figure 5A ). The alloresponse was always weaker than the reactivity to bovine RNase peptide offered by A k -expressing APCs. That this alloreactivity is the basis for arthritis development in KRNxNOD mice was strongly suggested by results from a series of crosses substituting other MHC alleles in place of the NOD-derived ( Figure 5B ). There was a perfect correlation between the appearance of arthritis in the F1 offspring and allorecognition of their down-modulation, anergy induction. We examined the All from transgenics except (B), which was a negative littermate.
T cells in KRNxNOD animals to see whether they were subject to analogous tolerization events. Figure 6A compares numbers and CD4/CD8 profiles course, histology) that in KRN mice harboring the entire complement of NOD genes.
of receptors were easy to detect, predominantly on V ␤ 6 hi cells (lower box). Introduction of the TCR-␣ null mutation onto the B6xNOD background had two effects. As expected, T cells no longer displayed V ␣ 2 ϩ TCRs (lower box)-the mutation permitted expression of transgeneencoded V ␣ 4 only, so all cells expressed this and only this V ␣ . In addition, T cells displaying the highest levels of V ␤ 6 ϩ TCRs were much rarer (upper and middle boxes). This implied that the CD4 ϩ T cells in KRNxNOD mice could express high levels of one or the other of the transgene-encoded chains, but usually not both. Hence, it seems quite plausible that thymocytes expressing the potentially autoreactive receptors escaped clonal deletion because incomplete allelic exclusion permitted rearrangement and expression of endogenous TCR-␣ and -␤ genes and thereby reduced levels of the transgene-encoded specificity.
Many of the peripheral cells in weeks-old KRNxNOD mice exhibited signs of prior activation (data not shown). A greater proportion expressed late activation markers (CD44   hi   , CD62L lo , CD45RB lo ) than in transgene-negative littermates (2-4 times), but there was only a small increase in the fraction displaying early activation markers (CD25 hi , CD69 hi ). Despite their increased expression of certain activation markers, the peripheral T cells from KRNxNOD mice appeared functionally compromised: although normally reactive to polyclonal stimulators like anti-CD3, they specific cells were poorly responsive rather than poorly represented in KRNxNOD mice because the majority of was reflected in the peripheral T cell compartments, as hybridomas derived from lymph node cells after polysingle-positive lymph node and spleen cells also did not clonal stimulation with anti-CD3 produced IL-2 when appear in significant numbers until after 3 weeks, and challenged with the bovine RNase peptide in the presthe CD4 ϩ population never reached normal size (3.1-ence of APCs expressing A k ( Figure 7B ). Dose-response fold average reduction, n ϭ 8; not shown).
curves for hybridomas derived from transgene-positive Figure 6B examines TCR usage on peripheral CD4 ϩ B6 and B6xNOD animals overlapped. Hybridomas that cells of 7 week-old KRN transgenics carried on the B6 responded to the bovine RNase peptide presented by versus B6xNOD genetic background, or on the B6xNOD A k could also be stimulated alloreactively by NOD APCs background bearing a homozygous null mutation of the (not shown). endogenous TCR-␣ locus (Philpott et al., 1992) . The goal Finally, although technically demanding, it was possiwas to determine whether muted levels of the transgeneble to examine the few T cells present in ankle synovial encoded TCR might account for the ability of the potenfluid. The most important observations were that: (1) tially autoreactive T cells to escape from the thymus in there was a shift in the CD4/CD8 profile in comparison older animals. In B6 mice, transgene-encoded V ␤ 6 ϩ with that characteristic of lymph node, spleen, or blood TCRs were expressed at high levels on most CD4 ϩ cells lymphocytes, with a marked enrichment for CD4 ϩ cells (upper box); however, there was a shoulder of reduced ( Figure 6C ); (2) the CD4 ϩ population was enriched for staining and this corresponded to cells displaying encells displaying high levels of the transgene-encoded dogenously encoded V ␤ s (shown for V ␤ 8 in the middle receptor ( Figure 6D ). (Although the latter observation box). The lack of an appropriate reagent precluded might be taken as indicative of a clonotype-specific requantitation of transgene-encoded V ␣ 4 ϩ receptors, but sponse in the joint, it is equally consistent with the abendogenously encoded V ␣ 2 hi TCRs were clearly detectsence of a response and consequent TCR down-regulaable (lower box). In B6xNOD mice, CD4
ϩ cells displaying tion.) Too few synovial fluid T cells could be isolated to test their reactivity in vitro. high levels of V ␤ 6 ϩ TCRs were seen, but now the majority into the periphery. Yet, the paltry clonotype reactivity strated (not shown) to completely coat CD4 ϩ cells for 3 to 4 weeks. As indicated in Figure 8A , treatment according to this protocol led to a complete block of disTaken together, the results on T cells from KRNxNOD mice indicate that the potentially autoreactive specificity ease initiation. That the blockade was only temporary is depicted in Figure 8B : about 5 to 6 weeks after antiis subject to two levels of tolerance induction: clonal deletion in the thymus and some form of anergy induc-CD4 treatment (and 4 to 5 weeks after disease routinely sets in) arthritis began; this corresponded to the reemertion in the periphery. Clonal deletion was efficient only until about 3 weeks of age; shortly afterwards, mature gence of substantial numbers of cells stainable with the anti-CD4 mAb (not shown). Anti-CD4 had to be adminis-T cells with muted levels of the autoreactive receptor escaped into the periphery and, nearly coincidently, the tered at least five days before disease onset to be effective; mice treated just at the time of ( Figure 8C ) or after first signs of arthritis appeared.
( Figure 8D ) initiation developed the usual arthritis. Given the B lymphocyte abnormalities in both KRN The Role of Lymphocytes in Disease Development-CD4 ؉ T and B Cells xNOD mice and human RA patients, we evaluated the influence of B cells on the development of arthritis in our Are Required The very nature of the KRNxNOD disease implies a critimodel. This was done by introducing the MTЊ mutation (Kitamura et al., 1991) in homozygous form, preventing cal role for T lymphocytes, i.e. arthritis only appeared when two elements were introduced onto the B6 backthe surface display of Ig heavy chains, resulting in the absence of a mature B cell compartment. KRNxNOD ground: the TCR genes originating from the R28 hybridoma and the A g7 genes. In addition, disease was first mice devoid of B cells showed no signs of arthritis, evaluated either by joint measurements ( Figure 8E ) or detectable just after significant numbers of mature T cells displaying transgene-encoded receptors emerged histological analyses (not shown). Although B cells were absent, T cells displaying the transgene-encoded recepparameters. The influence of genetics and environment on the panoply of abnormalities is not understood at tor underwent clonal deletion in the thymus, and transgene-encoded receptor levels on peripheral T cells present; so it is quite conceivable that the disease in genetically pure mice, housed in controlled environmenwere reduced as in KRNxNOD animals with a normal complement of B cells (not shown).
tal conditions, might not reproduce every aspect of the disorder in patients. A related point is that the mouse disease is more aggressive than the RA typically found Discussion in man, such that sites remaining intact in the latter (perhaps under the influence of drug treatment) are com-A New Model of Rheumatoid Arthritis promised in the former. KRNxNOD mice represent a new model of RA in man One needs also to situate the KRNxNOD strain in the as they spontaneously develop a highly reminiscent discontext of other models of RA (for reviews, see Henderease. Just how good a model is it? son et al., 1995) . A variety of induced small animal modArthritis in KRNxNOD mice shares most of the major els have been described, elicited by such agents as clinical, histological and immunological features of the bacteria, viruses, adjuvants or cartilage components. human disorder. It is a chronic progressive disease that On the other hand, few spontaneous models have been is first manifest by swelling of the joints, and evolves reported and most of these have not been explored to a point where multiple joint deformities significantly in great depth. Mice of the MRL/lpr strain, the most impair mobility. Articular involvement is strikingly symextensively studied example to date, often show histometrical and shows a marked distal preeminence, both logical, though rarely clinical, signs of polyarthritis, and characteristics of the human syndrome. Histological exhibit high concentrations of circulating RF and other analysis reveals the classical images of massive leukoautoantibodies (Andrews et al., 1978) . However, this is cyte infiltration, synovitis, pannus formation, cartilage primarily a lymphoproliferative disease, due to an alterdestruction, bone erosion followed by remodeling, and ation in the fas gene, and is probably more akin to sysfibrosis. Immunological evaluation demonstrates B lymtemic lupus erythrematosis than RA. DBA/1 mice can phocyte dysregulation, evidenced by increased B cell spontaneously develop polyarthritis (Nordling et al., numbers and hypergammaglobulinemia. In addition, the 1992), but it is asymmetric, intermittent, and migratory, critical dependence of the mouse disease on the MHC and shows little evidence of immune system involveclass II A g7 molecule recalls the long-studied influence ment. Two strains of mice exhibiting diseases reminisof particular class II alleles on the disorder in man cent of RA were recently engineered via transgenesis. (Wordsworth, 1992) .
In one (Iwakura et al., 1991) , the HTLV-1 genome was Nonetheless, the arthritides of KRNxNOD animals and introduced; the animals develop a chronic polyarthritis, human subjects differ in several details. Clinically, there but it is slow in onset and only partially penetrant (50% are a few discrepancies in the pattern of joint involveincidence at 1 year in females; even lower in males). In ment: the mice show attack of the distal interphalangeal the other (Keffer et al., 1991) , the transgene was a human joints and, sporadically, inflammation of the spine, while TNF-␣ gene modified in the 3Ј-untranslated region; humans generally do not. Histologically, there may be these animals show a chronic, destructive polyarthritis dissimilarities in the composition of the inflammatory at an early age with 100% incidence but, curiously, the infiltrate, as the large excess of myeloid cells over T same disorder is exhibited by transgenics rendered delymphocytes and plasma cells in the inflamed synovial void of an immune system (cited in Feldmann et al., membrane of KRNxNOD mice appears more extreme 1996a). than usually described for patient material. (Although Thus, it would appear that the KRNxNOD model reprepatient histology, itself, is highly variable, making it diffisents a potentially important tool for studying RA-both cult to assess the real magnitude of this dissimilarity.)
for exploring the mechanism of disease development Immunologically, the most striking discordance is in the and for testing new therapeutic strategies. Its usefulness profile of autoantibodies detected: RF, present at eleshould be enhanced by several features: 100% disease vated concentrations in ‫%07ف‬ of RA patients, is not incidence, an early and reproducible time of onset, a observed in KRNxNOD animals; conversely, IgG deposhighly predictable disease course. In addition, its being its coat many of the organs in the mouse model but a TCR transgenic system highlights and greatly simplithis has not been reported for patients. However, the fies the contribution made by lymphocytes and should significance of RF and other autoantibodies in arthritis thus permit new approaches to dissecting the role of pathology has been questioned (Feldmann et al., 1996b) , the immune system in pathology. and the murine/human differences could just reflect species-specific variations in B cell physiology-variant outcomes of massive B cell stimulation.
The Mechanism of Arthritis Development in KRNxNOD Mice In evaluating the significance of these differences, one should bear in mind several considerations. Mice
The R28 T cell hybridoma responds alloreactively to APCs from NOD mice due to recognition of the MHC and men obviously show dissimilarities in physiologyperhaps most relevant here would be their divergent class II A g7 molecule; consequently, T cells from mice carrying rearranged TCR genes from R28 and A g7 genes postures and modes of locomotion. Thus, it is not too surprising that a disease of the joints might differ in from the NOD strain should exhibit systemic autoreactivity. That they do is readily apparent from an analysis of details. In addition, RA in humans is a highly variable syndrome, showing significant diversity in a number of T lymphocyte compartments in KRNxNOD mice. The thymus shows a clear deletion profile until 3 weeks of II molecule expression on a variety of cell types that usually display none or little, including synoviocytes. age; around that time, mature T cells appear in the thymus and periphery, although their numbers never quite Aberrant activation of these cells could then result from recognition of their A g7 molecules by the transgenereach normal levels. Peripheral T cells are characterized by a reduced display of the transgene-encoded TCR encoded TCR, and this activation might set off a sequence of events leading to arthritis. It is highly (coupled with frequent expression of endogenously encoded receptors) and by poor responsiveness. Neversuggestive that MHC class II molecules are lymphokineinducible on macrophages and synovial fibroblasts and theless, their emergence coincides with the first clinical and histological signs of arthritis. Thus, one gets the that their engagement leads to the production of a variety of mediators, including TNF-␣, IL-1␤, nitric oxide, impression of autoreactivity that is largely contained, but not totally eliminated, by multiple tiers of tolerance IL-6, and IL-8 (Alvaro-Gracia et al., 1989; Trede et al., 1991; Mourad et al., 1992; Mehindate et al., 1994) . Third, induction. Why deletion is so partial after 3 weeks is unknown and will probably remain so until we learn more specificity could be imposed by the physiology of the joint: it is poorly vascularized and subject to mechanical about the exact ligand recognized-A g7 irrespective of peptide? plus multiple peptides? plus a single peptide? stress, factors that might combine to create an environment of low oxidative state. Redox balance is known to (We do know that the ligand is not the corresponding mouse RNase peptide presented by A g7 ). Presumably, modulate the synthesis or activity of transcription factors expressed by T cells (Ivanov et al., 1993) and is some alteration in the population of thymic stromal cells or in their expression of A g7 or its peptide complement suspected to underlie the control that bcl-2 exerts on apoptosis (Hockenbery et al., 1993) . Thus, it is possible occurs around this time, perhaps related to the vast hormonal changes taking place at weaning. That the that different programs unfold when T cells in the joint, versus those in the lymphoid organs and other tissues, partiality of clonal inactivation may be key is suggested by the KRNxDBA/2 cross, which introduced the mls1 a are stimulated-in the former case, biased towards proliferation and cytokine production; in the latter, towards superantigen: offspring exhibited clonal deletion more extreme than that found in KRNxNOD mice and no signs anergy or death. Alternatively, or in addition, the poor vacularization and mechanical stress of the joint could of arthritis were apparent (Table 1) .
The low level of systemic autoreactivity persisting in result in ineffectual clearance of immune complexes issuing from polyclonal B cell activation and, by conseKRNxNOD mice is manifest as an organ-specific disease. Although we do not yet know how this comes quence, stimulation of the complement cascade and induction of inflammatory cytokines. about, we do have in hand several pieces of information that provide important leads. The anti-CD4 experiments Whatever the mechanism turns out to be, one aspect should be highlighted-systemic autoreactivity can prodemonstrate a critical role for CD4 ϩ T cells and further reveal that they perform their required function(s) very voke an organ-specific disease. Wide distribution of the inciting antigen/A g7 complex is indicated by the deletion early in disease course-anti-CD4 treatment just prior to or after disease onset provides no benefit. The studies of immature T cells in the thymus and by the ability of splenocytes to stimulate R28 T cells in vitro. That the on mice carrying the MTЊ mutation, and thereby lacking a mature B lymphocyte compartment, show an impordistribution does not just reflect the binding of circulating antigen by A g7 displayed on APCs is suggested by tant role for B cells. This could be either as antibody producers or as antigen presentors, or could reflect the finding that a B hybridoma derived from NOD splenocytes and cultured for months also stimulates R28 cells some more indirect function. Lastly, joint histology and cytokine profiles argue for the involvement of cells of the in vitro. myeloid lineage, perhaps as producers of inflammatory factors such as TNF-␣ and IL-6.
Implications for the Mechanism(s) of Disease Considered in their ensemble, these leads suggest sevDevelopment in Other Models and Patients eral possible scenarios for the development of arthritis in One is led to question whether the disease in other RA the KRNxNOD model. First, the key to joint specificity models or in RA patients might not arise from a similar could lie in the abnormal activation of B lymphocytes:
systemic, rather than joint-specific, provocation. essentially all B cells constitutively display A g7 and should Certainly there are some models where the mechathus be recognized by T cells expressing the transgenenism of disease is likely to involve primarily systemic encoded TCR and be delivered "help" that is aberrant in stimulation. For example, the arthritis in animals infected its universality and route of delivery, i.e. independent of by mycoplasma arthritides could unfold in a very similar the Ig receptor. The outcome could be high level synthesis, fashion to that in KRNxNOD mice. Upon infection, this either systemically or locally, of an unusual combination microbe produces a superantigen, mycoplasma arthritis of lymphokines and other mediators, which might promote mitogen, which can bridge MHC molecules and TCRs synovitis and recruitment of leukocytes into the joint. Secor directly trigger cells through their MHC molecules, ond, aberrant activation of a cell population residing in thereby inciting polyclonal T and B cell activation and the normal synovium could be the basis of joint specificity.
the production of inflammatory cytokines (TNF-␣, IL-1, Polyclonal activation of both T and B lymphocytes should IL-6) by monocytes. This superantigen has already been take place in KRNxNOD mice due to mutual stimulation directly implicated in arthritis exacerbation (Cole and via the TCR-MHC class II molecule interaction, resulting Sawitzke, 1995) . Another model to consider in this conin differentiation, lymphokine secretion, and altered text is the transgenic mouse line carrying a modified homing properties. The lymphokines produced, e.g. IFN-␥, TNF-␣, IL-4, would be capable of inducing class human TNF-␣ gene (Keffer et al., 1991) . These animals
Antibodies and Flow Cytometry
express TNF-␣ in a deregulated fashion throughout the Preparation of thymus, lymph node, and spleen cell suspensions, body and develop an arthritis apparently quite similar their staining for flow cytometry, and the mAbs used were as deto that in KRNxNOD mice, except that it appears to be scribed (Cosgrove et al., 1991; Wang et al., 1996) . Synovial fluid cell independent of lymphocytes (cited in Feldmann et al.,
suspensions were made after several ankle punctures; the viscous 1996a). We suggest that the diseases in the two models fluid leaking out (3-20 l) was diluted in PBS/EDTA and centrifuged. Determination of circulating Ig levels was performed by ELISA might depend on a similar mechanism of pathogenesis, (Cosgrove et al., 1991) . Assays for autoantibodies included immunobut that the TNF-␣ transgenic model just initiates further fluorescence on cryostat sections of mouse liver and kidney (1/50 downstream, after any inciting systemic autoreaction.
serum dilutions, goat anti-mouse-IgG/FITC second step), ELISA with
The HTLV-1 transgenic model (Iwakura et al., 1991) dsDNA or mouse IgG as target antigens (with goat-anti-mousemight also fit somewhere along this pathway, as high Tax protein, have been reported in these animals.
Histology
There are also suggestions that systemic reactivity context, it might be worth reconsidering the basis for RA association with particular MHC alleles: some alleles, order to elaborate the complete pathway from systemic
To derive T cell hybridomas from the transgenic mice, spleen or provocation to joint-specific disease.
lymph node cells were stimulated with anti-CD3 for 24 hr in vitro, fused to BW5147␣-␤-, and the hybrids selected in HAT medium. These hybridomas were tested for IL-2 production after 24 hr stimuExperimental Procedures lation in the presence of 3 ϫ 10 5 B10.BR splenocytes and RNase peptide 41-61, or of graded numbers of NOD splenocytes. IL-2 Mice production was detected by incorporation of 3 H-thymidine by the The A␤ g7 transgenic line on the BALB/c background was a gift from CTLL indicator line. D. Wherrett and H. McDevitt. The B6.H2 g7 congenic line was provided by H. Kikutani. The MTЊ and TCRaЊ knockout lines (Kitamura Acknowledgments et al., 1991; Philpott et al., 1992) Candé ais for sequencing; J.-L. Pasquali and T. Martin for help with autoantibody determination; C. Marfing, P. André , and M. Duval for help with the transgenics; P. Michel, F. Mackay, C. Schricke, F.
DNA Constructs and Transgenesis
The sequences of the variable regions of the ␣ and ␤ chains of the Fischer, and the staff of the CDTA/CNRS for maintaining the mice; P. Eberling for peptides; J. L. Vonesh and C. Waltzinger for fluores-R28 hybridoma were determined as previously described (Candeias et al., 1991) . From this information, rearranged V␣4J␣27 and cence analysis; B. Boulange and T. Ding for sections; and C. Ebel, P. Gerber, and J. Hergueux for assistance. This work was supported V␤6J␤1.5 genomic DNA fragments were amplified and cloned into TCR expression cassettes (Kouskoff et al., 1995) , yielding plasmids by institutional funds from the INSERM, the CNRS, Bristol-Myers/ Squibb, the Centre Hospitalier Universitaire Ré gional, and by grants paKRN and pbKRN. Large fragments were excised and injected into fertilized B6xSJL F2 eggs. Screening of the transgenic founders to D. M. and C. B. from the Association pour la Recherche sur la Polyarthrite and the Human Frontier Science Program. VK was was performed on Southern blots with an 800 bp XmaI-NotI VJ␣ probe from paKRN or with a 1.6 kb EcoRI probe from the germline supported by the Ligue Nationale contre le Cancer. J␤2 region. A single founder in which TCR␣ and -␤ transgenes were cointegrated was identified.
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